Cargando…
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596415/ https://www.ncbi.nlm.nih.gov/pubmed/33178016 http://dx.doi.org/10.3389/fphar.2020.563478 |
_version_ | 1783602103118200832 |
---|---|
author | Hossain, Md. Farhad Hasana, Sharifa Mamun, Abdullah Al Uddin, Md. Sahab Wahed, Mir Imam Ibne Sarker, Sabarni Behl, Tapan Ullah, Irfan Begum, Yesmin Bulbul, Israt Jahan Amran, Md. Shah Rahman, Md. Habibur Bin-Jumah, May N. Alkahtani, Saad Mousa, Shaker A. Aleya, Lotfi Abdel-Daim, Mohamed M. |
author_facet | Hossain, Md. Farhad Hasana, Sharifa Mamun, Abdullah Al Uddin, Md. Sahab Wahed, Mir Imam Ibne Sarker, Sabarni Behl, Tapan Ullah, Irfan Begum, Yesmin Bulbul, Israt Jahan Amran, Md. Shah Rahman, Md. Habibur Bin-Jumah, May N. Alkahtani, Saad Mousa, Shaker A. Aleya, Lotfi Abdel-Daim, Mohamed M. |
author_sort | Hossain, Md. Farhad |
collection | PubMed |
description | At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). |
format | Online Article Text |
id | pubmed-7596415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75964152020-11-10 COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management Hossain, Md. Farhad Hasana, Sharifa Mamun, Abdullah Al Uddin, Md. Sahab Wahed, Mir Imam Ibne Sarker, Sabarni Behl, Tapan Ullah, Irfan Begum, Yesmin Bulbul, Israt Jahan Amran, Md. Shah Rahman, Md. Habibur Bin-Jumah, May N. Alkahtani, Saad Mousa, Shaker A. Aleya, Lotfi Abdel-Daim, Mohamed M. Front Pharmacol Pharmacology At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). Frontiers Media S.A. 2020-10-16 /pmc/articles/PMC7596415/ /pubmed/33178016 http://dx.doi.org/10.3389/fphar.2020.563478 Text en Copyright © 2020 Hossain, Hasana, Mamun, Uddin, Wahed, Sarker, Behl, Ullah, Begum, Bulbul, Amran, Rahman, Bin-Jumah, Alkahtani, Mousa, Aleya and Abdel-Daim http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Hossain, Md. Farhad Hasana, Sharifa Mamun, Abdullah Al Uddin, Md. Sahab Wahed, Mir Imam Ibne Sarker, Sabarni Behl, Tapan Ullah, Irfan Begum, Yesmin Bulbul, Israt Jahan Amran, Md. Shah Rahman, Md. Habibur Bin-Jumah, May N. Alkahtani, Saad Mousa, Shaker A. Aleya, Lotfi Abdel-Daim, Mohamed M. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title | COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title_full | COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title_fullStr | COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title_full_unstemmed | COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title_short | COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
title_sort | covid-19 outbreak: pathogenesis, current therapies, and potentials for future management |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596415/ https://www.ncbi.nlm.nih.gov/pubmed/33178016 http://dx.doi.org/10.3389/fphar.2020.563478 |
work_keys_str_mv | AT hossainmdfarhad covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT hasanasharifa covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT mamunabdullahal covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT uddinmdsahab covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT wahedmirimamibne covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT sarkersabarni covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT behltapan covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT ullahirfan covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT begumyesmin covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT bulbulisratjahan covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT amranmdshah covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT rahmanmdhabibur covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT binjumahmayn covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT alkahtanisaad covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT mousashakera covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT aleyalotfi covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement AT abdeldaimmohamedm covid19outbreakpathogenesiscurrenttherapiesandpotentialsforfuturemanagement |